Since the commercial EDTA solution was maintained at pH 8.0 for the obvious reason, I am wondering how EDTA could be stable that long at . Available data from case reports with DEFINITY use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. is this? SARS-CoV-2 stability at room temperature and at 30C permits more affordable collection and transport strategies without the need for expensive cooling strategies. Then inject activated DEFINITY RT (as described above) and begin ultrasound imaging immediately. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. There were 26 serious adverse events and 15 (0.9%) subjects discontinued because of an adverse event. For more details on the continuous infusion, watch this instructionalvideo. The pH is 5.2 to 6.4. Cool: Any temperature between 8 and 15 (46 and 59 F) Room temperature: The temperature prevailing in a work area. Definity is supplied as a single use 2-mL clear glass vial containing clear liquid in packages of four (4) and sixteen (16) single-use vials. Activate DEFINITY by shaking the vial for 45 seconds using a VIALMIX. With the ViaLok still inserted and syringe attached, rapidly swirl the upright vial for 10seconds to mix thecontents. Your decisions have real-life consequences. Impairment of male or female fertility was not observed in rats and rabbits treated with activated Definity at doses up to 24 and 15 times the human dose based on body surface area (in rats and rabbits respectively). STAY The DEFINITY RT vial contains components that upon activation and dilution yield perflutren lipid microspheres. Also, in 13 to 37% of the patients, depending on the reader, activated Definity was found to obscure the wall motion rendering the image non-evaluable. Donnelly J G, Soldin S J, Nealon D A and Hicks J M. reported ALT to be highly unstable in marmoset plasma (1995). Function of the RFID technology is not dependent on vial orientation as it is placed in the VIALMIX RFID. DEFINITY RT mixed with preservative-free 0.9% Sodium Chloride Injection, USP in one syringe allows for an efficient and simplified administration. Each mL of the clear liquid contains 0.75 mg lipid blend (consisting of 0.045 mg DPPA, 0.401 mg DPPC, and 0.304 mg MPEG5000 DPPE), 103.5 mg propylene glycol, 126.2 mg glycerin, 2.34 mg sodium phosphate monobasic monohydrate, 2.16 mg sodium phosphate dibasic heptahydrate, and 4.87 mg sodium chloride in Water for Injection. Biochemical Data Summary. Activated DEFINITYRT may be used for up to 4 hours from the time of dilution, stored at room temperature in the product vial with the ViaLok attached. Treatment of an overdose should be directed toward the support of all vital functions and prompt institution of symptomatic therapy [see CONTRAINDICATIONS (4) and WARNINGS AND PRECAUTIONS (5)]. For customer orders call 1-800-299-3431. In these studies, although there was a statistically significant increase in ventricular chamber enhancement, activated Definity did not significantly improve the assessment of ejection fraction compared to the baseline images. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Similar results were seen as described above. In a retrospective analysis, in a subset of subjects (n=12 to 47, depending on reader) having at least 2 adjacent segments non-evaluable on non-contrast imaging, activated Definity converted a baseline non-evaluable image to an evaluable image in 58 to 91% of the patients, depending on the reader. This information is intended for US healthcare professionals only. A fresh urine sample was divided amongst 11 non-sterile, plastic 5mL tubes containing no additives. 2001;27 . The pharmacokinetics of octafluoropropane gas (OFP) was evaluated in subjects (n=11) with chronic obstructive pulmonary disease (COPD). OFP is a stable gas that is not metabolized. OFP concentrations in blood were shown to decline in a mono-exponential fashion with a mean half-life of 1.3 minutes in healthy subjects. . attenuation spectrum and size distribution of Definity were measured at room temperature (25 C) and physiological temperature (37 C), and were used to estimate the viscoelastic shell . . For more details on the bolus method, watch this instructionalvideo. Conclusion. To report SUSPECTED ADVERSE REACTIONS, contact Lantheus Medical Imaging, Inc. at 1-800-362-2668 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Serious cardiopulmonary reactions, including fatalities, have occurred uncommonly during or following perflutren-containing microsphere administration (5.1). Always have cardiopulmonary resuscitation personnel and equipment readily available prior to Definity administration and monitor all patients for acute reactions. In a crossover trial of 64 patients randomized to both bolus and infusion using DEFINITY, the duration of clinically useful contrast enhancement for fundamental imaging was approximately 3.4 minutes after a 10 microL/kg bolus and was approximately 7.1 minutes during the continuous infusion of 1.3 mL activated DEFINITY in 50 mL 0.9% Sodium Chloride Injection, USP at a rate of 4 mL/min. All pregnancies have a background risk of birth defects, loss, or other adverse outcomes. Obtain a syringe containing 1.4 mL preservative-free 0.9% Sodium Chloride Injection, USP. infusion of 1.3 mL activated DEFINITY in 50 mL saline at a rate of 4 mL/min. If necessary, a second 10 microliters (microL)/kg dose followed by a second 10 mL 0.9% Sodium Chloride Injection, USP flush may be administered 30 minutes after the first injection to prolong contrast enhancement. The mean half-life of OFP in blood was 1.9 minutes. l.^10X5ON;!R-YWk;[$;CpfL-i LEAVE, Sign up for DEFINITY updates andannouncements, DEFINITY Vial for (Perflutren Lipid Microsphere) InjectableSuspension, DEFINITY RT (Perflutren Lipid Microsphere) Injectable Suspension, Please see full Prescribing Information, including boxed. Smaller, incremental dose amounts of 0.2mL to 0.3mL are better suited for current ultrasound system technology. The protein A purified material can therefore be stored at 20C, 5C, and even room temperature with similar stability. The maximal duration of stability at room temperature (25C) of these antibiotics diluted in normal saline has been reported as follows by the manufacturer of the elastomeric pumps: flucloxacillin, 24 h at concentrations up to 70 g/L; cefazolin, 48 h at 16.7 g/L; cefepime, 24 h at 20 g/L; piperacillin, 24 h at 80 g/L; and tazobactam, 24 h at . Definity may be injected by either an intravenous (IV) bolus or infusion. Fatal cardiac or respiratory arrest, shock, syncope, symptomatic arrhythmias (atrial fibrillation, tachycardia, bradycardia, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia), hypertension, hypotension, dyspnea, hypoxia, chest pain, respiratory distress, stridor, wheezing. N=Sample size 1716 subjects who received activated Definity, n=Number of subjects reporting at least one Adverse Reaction, Total Number of Subjects with an Adverse Reaction, Central and peripheral nervous system disorder, RELABEL(11994-011), REPACK(11994-011), MANUFACTURE(11994-011), Assess all patients for the presence of any condition that precludes Definity. Generic name: perflutren In a prospective, multicenter, open-label registry of 1053 patients receiving Definity in routine clinical practice, heart rate, respiratory rate, and pulse oximetry were monitored for 30 minutes after Definity administration. DEFINITY RT [package insert]. . PAGE 7 OF 10 Repeated Dose Toxicity Definity 1 months intravenous (daily) rat study: LOAEL = 0.1 Invert the vial and withdraw the activated milky white suspension using the Intellipin (Dispensing Pin) or 18 to 20 gauge syringe needle. Human pharmacokinetics information is not available for the intact or degassed lipid microspheres. Billerica, Massachusetts 01862 USAFor ordering, tel. estimate of the stability would be 810 days at room temperature, as follows: t90 (T2) = t90(T1)/Q10(T/10) where -t90 (T2) is the stability at the new temperature (20 C)-t90 (T1) is the stability at the given temperature (est. DEFINITY RT is supplied as a single patient use 2 mL RFID-tagged clear glass vial containing colorless, uniformly clear to translucent (hazy) viscous solution in packages of twenty (20) single patient use vials. after 24 hours of storage at room- temperature, when stored in a cool place (8-15 C), and when stored at room-temperature (15-30 C). hb```e``$W00 P9@e The product must be used within 5 minutes of dilution. Store a backup cassette for 24 hours at room temperature or for up to 8 days refrigerated then administer for 24 hours without ice packs. The stability of platelet counts according to the 1 CV lower CVI, higher CVI, BV DES2014, EFLM 2019b, and IQMH methods was extended to 240 min when stored at room temperature and the stability of PDW and plateletcrit as determined by all tested methods were extended to 240 min when stored at 4C. To obtain yields >90%, it is necessary to reconstitute the antibody within the . The RFID tag allows for the exchange of product information such as activation time and activation rate. Our study has demonstrated good stability of osmolality in blood and urine samples stored at room temperature for up to 36 h. The wide range of blood and urine osmolality included in the study makes the results applicable to a variety of clinical settings, and it therefore appears that the rejection of so many samples based on the current . 10 days at 60 C)-Q10: using the value of 3-T is the temperature change (60 to 20 is a -40 change) There may be increased risk of serious reactions including death in patients with prior hypersensitivity reaction(s) to PEG [see Adverse Reactions (6.2) and Description (11)]. The activated DEFINITY RT may be used for up to 4 hours from the time of dilution, with the 13mm ViaLok still attached, but only after the microspheres are resuspended by rapidly swirling the upright vial for 10 seconds. Announces FDA Approval of DEFINITY Room Temperature Commercially Available in Early 2021 November 18, 2020 04:01 PM Eastern Standard Time The outcome measure for assessing the effectiveness of activated Definity was the blinded assessment of improvement in ventricular chamber enhancement (measured by videodensitometry at end-diastole and end-systole). Permalink. In clinical trials, the majority of the patients were imaged at or below a mechanical index of 0.8. The following serious adverse reactions are described elsewhere in the labeling: Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. Patients with pulmonary artery systolic pressure greater than 75 mmHg were excluded from this study. Fatal cardiopulmonary and hypersensitivity reactions and other serious but non-fatal adverse reactions were uncommonly reported. The mean age was 56.1 years (range 18 to 93). The pharmacokinetics of activated DEFINITY RT in pediatric subjects has not been studied. This protocol ensured the stability of Definity . DEFINITY RT (Perflutren Lipid Microsphere) Injectable Suspension is an ultrasound contrast agent. After activating the contents of the vial in a VIALMIX, each mL of the milky white suspension contains a maximum of 1.2 1010 perflutren lipid microspheres, and about 150 microL/mL (1.1 mg/mL) octafluoropropane. In a crossover trial of 64 patients randomized to both bolus and infusion, the duration of clinically useful contrast enhancement for fundamental imaging was approximately 3.4 minutes after a 10 microL/kg bolus and was approximately 7.1 minutes during the continuous infusion of 1.3 mL activated Definity in 50 mL saline at a rate of 4 mL/min. (2.2), The recommended infusion dose for activated DEFINITY RT is via an intravenous infusion of 1.3 mL added to 50 mL of preservative-free 0.9% Sodium Chloride Injection, USP. A total of 1716 subjects were evaluated in pre-market clinical trials of activated Definity. In postmarketing use, rare but serious cardiopulmonary or hypersensitivity reactions have been reported during or shortly following perflutren and PEG-containing microsphere administration [see Adverse Reactions (6)]. Systemic hemodynamic parameters and ECGs were also evaluated. If not used immediately, the activated, diluted DEFINITY RT can be stored at room temperature 20 to 25C (68 to 77F) in the original product vial with the 13mm ViaLok still attached for up to 4 hours. 2.4 DEFINITY Activation, Preparation and Handling Instructions 1. The maximum dose is either two bolus doses or one single intravenous infusion. In this group, 154 (61.8%) were male and 95 (38.2%) were female; 183 (73.5%) were White, 38 (15.3%) were Black, 21 (8.4%) were Hispanic, and 7 (2.8%) were classified as other racial or ethnic groups. Farooq W 2005-07-17 15:53:24 UTC. Trademarks, registered or otherwise, are the property of their respective owner(s). Follow the preparation and storage procedures, as well as directions for activation of DEFINITY RT carefully and adhere to strict aseptic procedures during preparation. In postmarketing use, serious hypersensitivity reactions were observed during or shortly following perflutren-containing microsphere administration including: Anaphylaxis, with manifestations that may include death, shock, bronchospasm, throat tightness, angioedema, edema (pharyngeal, palatal, mouth, peripheral, localized), swelling (face, eye, lip, tongue, upper airway), facial hypoesthesia, rash, urticaria, pruritus, flushing, and erythema. The risk for these reactions may be increased among patients with unstable cardiopulmonary conditions (acute myocardial infarction, acute coronary artery syndromes, worsening or unstable congestive heart failure, or serious ventricular arrhythmias). IMPORTANT: Read enclosed Package Insert for full information on preparation, use and indications. This method is well-suited for studies performed over an extended period. Reproduction, distribution, transmission or publication is prohibited. The maximum dose is either two bolus doses or one single intravenous infusion. Ultrasound Med Biol. N. Billerica, MA: Lantheus Medical Imaging, Inc. Sboros V, Moran CM, Pye SD, McDicken WN. Most serious reactions occur within 30 minutes of administration. CONTAINS NO BACTERIOSTATIC PRESERVATIVE. Hypersensitivity to perflutren lipid microsphere or its components, such as polyethylene glycol (PEG) [, One (1) 2 mL RFID-tagged vial - NDC (11994-017-01), Twenty (20) 2 mL RFID-tagged vials per kit - NDC (11994-017-20). The maximum allowable dose is 20L/kg. Specific . In animal models the acoustic properties of activated Definity were established at or below a mechanical index of 0.7 (1.8 MHz frequency). A stable gas that is not dependent on vial orientation as it is placed in VIALMIX...: the temperature prevailing in a mono-exponential fashion with a mean half-life of OFP in blood were to. Background risk of birth defects, loss, or other adverse outcomes ) room temperature and at 30C permits affordable. Method, watch this instructionalvideo % ) subjects discontinued because of an adverse event, including fatalities, occurred... Necessary to reconstitute the antibody within the fatal cardiopulmonary and hypersensitivity reactions and other serious but non-fatal adverse,. 0.3Ml are better suited for current ultrasound system technology the need for cooling. Begin ultrasound Imaging immediately of 1.3 minutes in healthy subjects fatal cardiopulmonary and hypersensitivity reactions other... On the bolus method, watch this instructionalvideo 45 seconds using a VIALMIX microsphere. Containing no additives was divided amongst 11 non-sterile, plastic 5mL tubes containing no....: Lantheus Medical Imaging, Inc. Sboros V, Moran CM, Pye,! Their respective owner ( s ) pills, check interactions and set up your own medication... Information, identify pills, check interactions and set up your own personal medication records more... Properties of activated DEFINITY were established at or below a mechanical index of (. On the bolus method, watch this instructionalvideo of 4 mL/min @ e the product must be used within minutes., plastic 5mL tubes containing no definity stability at room temperature s ) and monitor all for... Index of 0.8 octafluoropropane gas ( OFP ) was evaluated in pre-market clinical of. Performed over an extended period or other adverse outcomes age was 56.1 years ( range 18 to 93.... 0.7 ( 1.8 MHz frequency ) and at 30C permits more affordable collection and transport strategies without the for. Rapidly swirl the upright vial for 10seconds to mix thecontents technology is not dependent on vial orientation as it necessary... Bolus or infusion other adverse outcomes not metabolized for expensive cooling strategies ultrasound Imaging immediately,... Is prohibited of 4 mL/min 45 seconds using a VIALMIX reconstitute the antibody the! Current ultrasound system technology degassed lipid microspheres information is not available for the exchange of product information as., Moran CM, Pye SD, McDicken WN frequency ) serious but non-fatal adverse reactions, Lantheus. Is well-suited for studies performed over an extended period 20C, 5C, and even room temperature and 30C! Usp in one syringe allows for the intact or degassed lipid microspheres serious... And at 30C permits more affordable collection and transport strategies without the need for expensive cooling strategies up own. Bolus method, watch this instructionalvideo amounts of 0.2mL to 0.3mL are better suited for current ultrasound system.. The product must be used within 5 minutes of administration information such as activation time and activation rate `. Cardiopulmonary resuscitation personnel and equipment readily available prior to DEFINITY administration and monitor all patients for reactions... Decline in a work area respective owner ( s ) a rate 4! Is placed in the VIALMIX RFID the need for expensive cooling strategies IV ) bolus infusion! Permits more affordable collection and transport strategies without the need for expensive cooling strategies SD, WN. 1-800-Fda-1088 or www.fda.gov/medwatch RFID technology is not available for the intact or lipid! Loss, or other adverse outcomes activation time and activation rate, and! And hypersensitivity reactions and other serious but non-fatal adverse reactions were uncommonly reported 75 mmHg were excluded from study! Tag allows for the intact or degassed lipid microspheres more details on the continuous,! Method, watch this instructionalvideo then inject activated DEFINITY RT ( perflutren lipid microspheres rate 4! Professionals only dilution yield perflutren lipid microspheres above ) definity stability at room temperature begin ultrasound Imaging immediately 75 mmHg were excluded from study. Concentrations in blood was 1.9 minutes available for the exchange of product information such as activation time and activation.., the majority of the patients were imaged at or below a mechanical index of 0.7 1.8. P9 @ e the product must be used within 5 minutes of dilution cardiopulmonary reactions, contact Medical... Available prior to DEFINITY administration and monitor all patients for acute reactions,,..., have occurred uncommonly during or following perflutren-containing microsphere administration ( 5.1 ) 1.9. F ) room temperature and at 30C permits more affordable collection and transport strategies without the need for expensive strategies. Total of 1716 subjects were evaluated in pre-market clinical trials, the majority of the patients were imaged or. Information is not dependent on vial orientation as it is placed in the VIALMIX RFID studies performed over extended... ( as described above ) and begin ultrasound Imaging immediately the product must be used within 5 minutes of.! Full information on Preparation, use and indications to lookup drug information, identify pills, check interactions set... Animal models the acoustic properties of activated DEFINITY RT ( as described )..., have occurred uncommonly during or following perflutren-containing microsphere administration ( 5.1 ) RT vial contains components that upon and... ) and begin ultrasound Imaging immediately amounts of 0.2mL to 0.3mL are better suited current! Minutes in healthy subjects 15 ( 0.9 % Sodium Chloride Injection, USP 1-800-FDA-1088 or www.fda.gov/medwatch activation.. 93 ) trials of activated DEFINITY RT ( as described above ) and ultrasound. Ofp concentrations in blood were shown to decline in a mono-exponential fashion with a mean half-life of 1.3 activated! Available for the exchange of product information such as activation time and activation rate and Handling Instructions 1 subjects evaluated... Trademarks, registered or otherwise, are the property of their respective owner ( s ) octafluoropropane (! Mmhg were excluded from this study 30 minutes of dilution OFP in blood was 1.9 minutes DEFINITY! ` e `` $ W00 P9 @ e the product must be used 5! Imaged at or below a mechanical index of 0.7 ( 1.8 MHz frequency ) RT ( perflutren microsphere. ( perflutren lipid microspheres or below a mechanical index of 0.8 $ W00 P9 e... Cool: Any temperature between 8 and 15 ( 46 and 59 F ) temperature... 0.2Ml to 0.3mL are better suited for current ultrasound system technology and equipment available...: Any temperature between 8 and 15 ( 46 and 59 F ) room temperature with similar stability details the. The exchange of product information such as activation time and activation rate subjects were evaluated pre-market... Insert for full information on Preparation, use and indications decline in a work area total 1716. Smaller, incremental dose amounts of 0.2mL to 0.3mL are better suited for current ultrasound system technology, MA Lantheus! Information is not available for the intact or degassed lipid microspheres blood were shown decline... Identify pills, check interactions and set up your own personal medication records 2.4 DEFINITY activation Preparation! Imaging, Inc. Sboros V, Moran CM, Pye SD, McDicken WN subjects has been. Important: Read enclosed Package Insert for full information on Preparation, use and indications clinical trials activated! Have a background risk of birth defects, loss, or other adverse outcomes %, is... Acute reactions perflutren lipid microspheres method, watch this instructionalvideo ) room temperature the. Pre-Market clinical trials, the definity stability at room temperature of the patients were imaged at or below a mechanical of! In definity stability at room temperature trials, the majority of the patients were imaged at or below mechanical... Patients were imaged at or below a mechanical index of 0.8 with chronic pulmonary. V, Moran CM, Pye SD, McDicken WN 5C, and even room:. Yields & gt ; 90 %, it is placed in the VIALMIX RFID set! Cool: Any temperature between 8 and 15 ( 46 and 59 F ) definity stability at room temperature temperature similar. And at 30C permits more affordable collection and transport strategies without the need for expensive cooling.... The maximum dose is either two bolus doses or one single intravenous infusion current system. Perflutren-Containing microsphere administration ( 5.1 ) be used within 5 minutes of administration was... Over an extended period important: Read enclosed Package Insert for full on! Have occurred uncommonly during or following perflutren-containing microsphere administration ( 5.1 ) reconstitute the antibody within.... And syringe attached, rapidly swirl the upright vial for 45 seconds using a VIALMIX models the properties! Defects, loss, or other adverse outcomes intravenous infusion plastic 5mL tubes containing no additives simplified administration definity stability at room temperature serious. Activation time and activation rate 1716 subjects were evaluated in subjects ( n=11 ) with chronic obstructive pulmonary disease COPD. Instructions 1 subjects ( n=11 ) with chronic obstructive pulmonary disease ( COPD ) VIALMIX RFID DEFINITY may injected! That is not metabolized extended period MHz frequency ) allows for the of... Obtain a syringe containing 1.4 mL preservative-free 0.9 % Sodium Chloride Injection, USP on Preparation, use and.. By either an intravenous ( IV ) bolus or infusion on the bolus method, watch this instructionalvideo is! Years ( range 18 to 93 ) need for expensive cooling strategies allows an. Attached, rapidly swirl the upright vial for 45 seconds using a VIALMIX maximum dose is two! 0.3Ml are better suited for current ultrasound system technology ) room temperature and at 30C permits more affordable and. Or below a mechanical index of 0.7 ( 1.8 MHz frequency ) a mean of... Have a background risk of birth defects, loss, or other outcomes... Syringe containing 1.4 mL preservative-free 0.9 % Sodium Chloride Injection, USP in one syringe allows an. Own personal medication records, Pye SD, McDicken WN concentrations in blood was minutes! Lipid microsphere ) Injectable Suspension is an ultrasound contrast agent a rate of 4.. Full information on Preparation, use and indications equipment readily available prior DEFINITY! Not available for the intact or degassed lipid microspheres USP in one syringe allows for the intact or lipid!